FDA Expands Use of Remdesivir for COVID-19 Treatment
August 31, 2020 — The Federal Drug Administration has broadened its emergency use authorization for the anti-viral drug remdesivir to include all hospitalized coronavirus patients, not just those who are so ill they require ventilators or oxygen therapy. “Today, as part of its ongoing efforts to fight COVID-19, the U.S. Food and Drug Administration broadened … Read more